SCHEMBL6154495

SCHEMBL6154495

Clc1ccc([N]Cc2ccc3ccccc3c2)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.42
CYP1A2 P05177 1/20 0.42
CTRC Q99895 1/20 0.39
SIGMAR1 Q99720 2/20 0.38
KMT2A Q03164 1/20 0.38
TMEM97 Q5BJF2 1/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2B Q13224 2/20 0.38
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
HTR3A P46098 1/20 0.36
HTR3D Q70Z44 1/20 0.36
HTR3C Q8WXA8 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PYCR1 P32322 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6158039 0.79 SIGMAR1 (0.39) CYP1A2SIGMAR1GRIN2BTAAR1HTR3E
SCHEMBL6008132 0.72 CYP1A2 (0.60) CYP2A6CYP1A2SIGMAR1KMT2AGRIN1
SCHEMBL1680341 0.71 CYP2A6 (0.59) CYP2A6CYP1A2SIGMAR1KMT2AGRIN1
SCHEMBL6157029 0.70 TSHR (0.53) KMT2A
SCHEMBL6153827 0.70 TSHR (0.54) CYP1A2KMT2AMAPK1TDP1PYCR1
SCHEMBL21469244 0.69 CYP1A2 (0.47) CYP2A6CYP1A2SIGMAR1KMT2AGRIN1
SCHEMBL6154500 0.68 INSR (0.59) CYP1A2KMT2A
SCHEMBL8009667 0.67 CYP1A2 (0.54) CYP2A6CYP1A2SIGMAR1KMT2AGRIN1
SCHEMBL12630751 0.67 CYP1A2 (0.54) CYP2A6CYP1A2SIGMAR1KMT2AHTR2A
SCHEMBL6155502 0.67 MEN1 (0.43) CYP1A2SIGMAR1KMT2AGRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP CYP2A6 4034/4885CYP1A2 4398/4885CTRC 4749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.